ArticleFrontiers in medicine2025
Development of a prognostic nomogram for ocular melanoma: a SEER population-based study (2000-2021).
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A nomogram to predict cancer-specific survival of ocular melanoma.Discover oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ocular melanoma (OM) is a rare but lethal subtype of melanoma. This study develops a prognostic nomogram for OM using machine learning and internal validation techniques, aiming to improve prognosis prediction and clinical decision-making. Methods: Independent prognostic variables were identified using univariate and multivariate COX proportional hazard regression models. Significant variables were then incorporated into the nomogram. The predictive accuracy of the nomogram was evaluated using receiver operating characteristic (ROC) curves, calibration plots, decision curve analysis (DCA), and 10-fold cross-validation. The performance of the nomogram was compared with that of a machine learning model. Results: Thirteen variables, including age, sex, tumor site, histologic subtype, stage, basal diameter size, tumor thickness, liver metastasis, first malignant primary indicator, marital status, and treatment modalities (surgery/radiotherapy/chemotherapy) were identified as independent prognostic factors for overall survival (OS) and were included in the nomogram (all Conclusions: A robust nomogram incorporating 13 significant clinicopathological variables was developed. The combined use of ROC curve analysis, calibration plots, DCA, 10-fold cross-validation, and machine learning confirmed the strong predictive performance of the nomogram for survival outcomes in patients with OM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.